Trademark Overview
On Friday, July 11, 2025, a trademark application was filed for FUSALIN with the United States Patent and Trademark Office. The USPTO has given the FUSALIN trademark a serial number of 99280271. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 11, 2025. This trademark is owned by Newcastle Bioecience, LLC. The FUSALIN trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations used to treat one or more of the following: infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, psychiatric conditions, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive diseases, and respiratory conditions